Generate Biomedicines Statistics
NASDAQ: GENBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.57-0.23 (-1.67%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Generate Biomedicines by the numbers
Generate Biomedicines has a market capitalization of $1.74 billion based on 128.35M shares outstanding. With trailing EPS of $-2.40, Generate Biomedicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.4% below its 50-day average and 4.1% below its 200-day average.
Average daily trading volume is 1.04M shares, or about $14.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GENB valuation vs. peer median
| Metric | GENB | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.74B | $1.80B | -3% |
| Avg. volume | 1.04M | 1.73M | -40% |
Peer median across 8 companies: BHVN, XNCR, NUVB, ZBIO, XERS, SRPT, SEPN, BRVE.
Valuation
- Market cap
- $1.74B
- EPS (TTM)
- $-2.40
- Shares outstanding
- 128.35M
Price and trading
- Previous close
- 13.80
- Open
- 13.58
- Day range
- 13.35 – 13.99
- 52-week range
- 11.00 – 22.67
- Beta
- —
- Volume
- 926.22K
- Average volume
- 1.04M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.74B
- Forward Pe
- -5.95
- Eps
- -2.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.67
- Week52 Low
- 11.00
- Avg Volume
- 1.04M
- Shares Outstanding
- 128.35M
- Ma50
- 15.49
- Ma200
- 14.15
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -40.14%
- Pct From52w Low
- 23.36%